Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

Note: Note: Starting October 10th, 2025 this dataset is deprecated and is no longer being updated. As of April 27, 2023 updates changed from daily to weekly. Summary The cumulative number of confirmed COVID-19 deaths among Maryland residents by age: 0-9; 10-19; 20-29; 30-39; 40-49; 50-59; 60-69; 70-79; 80+; Unknown. Description The MD COVID-19 - Confirmed Deaths by Age Distribution data layer is a collection of the statewide confirmed COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by designated age ranges. A death is classified as confirmed if the person had a laboratory-confirmed positive COVID-19 test result. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Probable deaths are available from the MD COVID-19 - Probable Deaths by Age Distribution data layer. Terms of Use The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.

Note: Data elements were retired from HERDS on 10/6/23 and this dataset was archived.

This dataset includes the cumulative number and percent of healthcare facility-reported fatalities for patients with lab-confirmed COVID-19 disease by reporting date and age group. This dataset does not include fatalities related to COVID-19 disease that did not occur at a hospital, nursing home, or adult care facility. The primary goal of publishing this dataset is to provide users with information about healthcare facility fatalities among patients with lab-confirmed COVID-19 disease.

The information in this dataset is also updated daily on the NYS COVID-19 Tracker at https://www.ny.gov/covid-19tracker.

The data source for this dataset is the daily COVID-19 survey through the New York State Department of Health (NYSDOH) Health Electronic Response Data System (HERDS). Hospitals, nursing homes, and adult care facilities are required to complete this survey daily. The information from the survey is used for statewide surveillance, planning, resource allocation, and emergency response activities. Hospitals began reporting for the HERDS COVID-19 survey in March 2020, while Nursing Homes and Adult Care Facilities began reporting in April 2020. It is important to note that fatalities related to COVID-19 disease that occurred prior to the first publication dates are also included.

The fatality numbers in this dataset are calculated by assigning age groups to each patient based on the patient age, then summing the patient fatalities within each age group, as of each reporting date. The statewide total fatality numbers are calculated by summing the number of fatalities across all age groups, by reporting date. The fatality percentages are calculated by dividing the number of fatalities in each age group by the statewide total number of fatalities, by reporting date. The fatality numbers represent the cumulative number of fatalities that have been reported as of each reporting date.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

Provisional deaths registration data for single year of age and average age of death (median and mean) of persons whose death involved coronavirus (COVID-19), England and Wales. Includes deaths due to COVID-19 and breakdowns by sex.

NOTE: This dataset has been retired and marked as historical-only. Weekly rates of COVID-19 cases, hospitalizations, and deaths among people living in Chicago by vaccination status and age. Rates for fully vaccinated and unvaccinated begin the week ending April 3, 2021 when COVID-19 vaccines became widely available in Chicago. Rates for boosted begin the week ending October 23, 2021 after booster shots were recommended by the Centers for Disease Control and Prevention (CDC) for adults 65+ years old and adults in certain populations and high risk occupational and institutional settings who received Pfizer or Moderna for their primary series or anyone who received the Johnson & Johnson vaccine. Chicago residency is based on home address, as reported in the Illinois Comprehensive Automated Immunization Registry Exchange (I-CARE) and Illinois National Electronic Disease Surveillance System (I-NEDSS). Outcomes: • Cases: People with a positive molecular (PCR) or antigen COVID-19 test result from an FDA-authorized COVID-19 test that was reported into I-NEDSS. A person can become re-infected with SARS-CoV-2 over time and so may be counted more than once in this dataset. Cases are counted by week the test specimen was collected. • Hospitalizations: COVID-19 cases who are hospitalized due to a documented COVID-19 related illness or who are admitted for any reason within 14 days of a positive SARS-CoV-2 test. Hospitalizations are counted by week of hospital admission. • Deaths: COVID-19 cases who died from COVID-19-related health complications as determined by vital records or a public health investigation. Deaths are counted by week of death. Vaccination status: • Fully vaccinated: Completion of primary series of a U.S. Food and Drug Administration (FDA)-authorized or approved COVID-19 vaccine at least 14 days prior to a positive test (with no other positive tests in the previous 45 days). • Boosted: Fully vaccinated with an additional or booster dose of any FDA-authorized or approved COVID-19 vaccine received at least 14 days prior to a positive test (with no other positive tests in the previous 45 days). • Unvaccinated: No evidence of having received a dose of an FDA-authorized or approved vaccine prior to a positive test. CLARIFYING NOTE: Those who started but did not complete all recommended doses of an FDA-authorized or approved vaccine prior to a positive test (i.e., partially vaccinated) are excluded from this dataset. Incidence rates for fully vaccinated but not boosted people (Vaccinated columns) are calculated as total fully vaccinated but not boosted with outcome divided by cumulative fully vaccinated but not boosted at the end of each week. Incidence rates for boosted (Boosted columns) are calculated as total boosted with outcome divided by cumulative boosted at the end of each week. Incidence rates for unvaccinated (Unvaccinated columns) are calculated as total unvaccinated with outcome divided by total population minus cumulative boosted, fully, and partially vaccinated at the end of each week. All rates are multiplied by 100,000. Incidence rate ratios (IRRs) are calculated by dividing the weekly incidence rates among unvaccinated people by those among fully vaccinated but not boosted and boosted people. Overall age-adjusted incidence rates and IRRs are standardized using the 2000 U.S. Census standard population. Population totals are from U.S. Census Bureau American Community Survey 1-year estimates for 2019. All data are provisional and subject to change. Information is updated as additional details are received and it is, in fact, very common for recent dates to be incomplete and to be updated as time goes on. This dataset reflects data known to CDPH at the time when the dataset is updated each week. Numbers in this dataset may differ from other public sources due to when data are reported and how City of Chicago boundaries are defined. For all datasets related to COVID-19, see https://data.cityofchic

Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.

Deaths involving COVID-19, pneumonia, and influenza reported to NCHS by sex, age group, and jurisdiction of occurrence.

Read the associated blogpost for a detailed description of how this dataset was prepared; plus extra code for producing animated maps.

Context

The 2019 Novel Coronavirus (COVID-19) continues to spread in countries around the world. This dataset provides daily updated number of reported cases & deaths in Germany on the federal state (Bundesland) and county (Landkreis/Stadtkreis) level. In April 2021 I added a dataset on vaccination progress. In addition, I provide geospatial shape files and general state-level population demographics to aid the analysis.

Content

The dataset consists of thre main csv files: covid_de.csv, demgraphics_de.csv, and covid_de_vaccines.csv. The geospatial shapes are included in the de_state.* files. See the column descriptions below for more detailed information.

• covid_de.csv: COVID-19 cases and deaths which will be updated daily. The original data are being collected by Germany's Robert Koch Institute and can be download through the National Platform for Geographic Data (the latter site also hosts an interactive dashboard). I reshaped and translated the data (using R tidyverse tools) to make it better accessible. This blogpost explains how I prepared the data, and describes how to produces animated maps.

• demographics_de.csv: General Demographic Data about Germany on the federal state level. Those have been downloaded from Germany's Federal Office for Statistics (Statistisches Bundesamt) through their Open Data platform GENESIS. The data reflect the (most recent available) estimates on 2018-12-31. You can find the corresponding table here.

• covid_de_vaccines.csv: In April 2021 I added this file that contains the Covid-19 vaccination progress for Germany as a whole. It details daily doses, broken down cumulatively by manufacturer, as well as the cumulative number of people having received their first and full vaccination. The earliest data are from 2020-12-27.

• de_state.*: Geospatial shape files for Germany's 16 federal states. Downloaded via Germany's Federal Agency for Cartography and Geodesy . Specifically, the shape file was obtained from this link.

Column Description

COVID-19 dataset covid_de.csv:

• state: Name of the German federal state. Germany has 16 federal states. I removed converted special characters from the original data.

• county: The name of the German Landkreis (LK) or Stadtkreis (SK), which correspond roughly to US counties.

• age_group: The COVID-19 data is being reported for 6 age groups: 0-4, 5-14, 15-34, 35-59, 60-79, and above 80 years old. As a shortcut the last category I'm using "80-99", but there might well be persons above 99 years old in this dataset. This column has a few NA entries.

• gender: Reported as male (M) or female (F). This column has a few NA entries.

• date: The calendar date of when a case or death were reported. There might be delays that will be corrected by retroactively assigning cases to earlier dates.

• cases: COVID-19 cases that have been confirmed through laboratory work. This and the following 2 columns are counts per day, not cumulative counts.

• deaths: COVID-19 related deaths.

• recovered: Recovered cases.

Demographic dataset demographics_de.csv:

• state, gender, age_group: same as above. The demographic data is available in higher age resolution, but I have binned it here to match the corresponding age groups in the covid_de.csv file.

• population: Population counts for the respective categories. These numbers reflect the (most recent available) estimates on 2018-12-31.

Vaccination progress dataset covid_de_vaccines.csv:

• date: calendar date of vaccination

• doses, doses_first, doses_second: Daily count of administered doses: total, 1st shot, 2nd shot.

• pfizer_cumul, moderna_cumul, astrazeneca_cumul: Daily cumulative number of administered vaccinations by manufacturer.

• persons_first_cumul, persons_full_cumul: Daily cumulative number of people having received their 1st shot and full vaccination, respectively.

Acknowledgements

All the data have been extracted from open data sources which are being gratefully acknowledged:

• The [Robert ...

Global Covid-19 Data

Global Covid-19 data on cases, deaths, vaccinations, and more

By Valtteri Kurkela [source]

About this dataset

The dataset is constantly updated and synced hourly to ensure up-to-date information. With over several columns available for analysis and exploration purposes, users can extract valuable insights from this extensive dataset.

Some of the key metrics covered in the dataset include:

1. Vaccinations: The dataset covers total vaccinations administered worldwide as well as breakdowns of people vaccinated per hundred people and fully vaccinated individuals per hundred people.

2. Testing & Positivity: Information on total tests conducted along with new tests conducted per thousand people is provided. Additionally, details on positive rate (percentage of positive Covid-19 tests out of all conducted) are included.

3. Hospital & ICU: Data on ICU patients and hospital patients are available along with corresponding figures normalized per million people. Weekly admissions to intensive care units and hospitals are also provided.

4. Confirmed Cases: The number of confirmed Covid-19 cases globally is captured in both absolute numbers as well as normalized values representing cases per million people.

5.Confirmed Deaths: Total confirmed deaths due to Covid-19 worldwide are provided with figures adjusted for population size (total deaths per million).

6.Reproduction Rate: The estimated reproduction rate (R) indicates the contagiousness of the virus within a particular country or region.

7.Policy Responses: Besides healthcare-related metrics, this comprehensive dataset includes policy responses implemented by countries or regions such as lockdown measures or travel restrictions.

8.Other Variables of InterestThe data encompasses various socioeconomic factors that may influence Covid-19 outcomes including population density,membership in a continent,gross domestic product(GDP)per capita;

For demographic factors: -Age Structure : percentage populations aged 65 and older,aged (70)older,median age -Gender-specific factors: Percentage of female smokers -Lifestyle-related factors: Diabetes prevalence rate and extreme poverty rate

1. Excess Mortality: The dataset further provides insights into excess mortality rates, indicating the percentage increase in deaths above the expected number based on historical data.

The dataset consists of numerous columns providing specific information for analysis, such as ISO code for countries/regions, location names,and units of measurement for different parameters.

Overall,this dataset serves as a valuable resource for researchers, analysts, and policymakers seeking to explore various aspects related to Covid-19

How to use the dataset

Introduction:

• Understanding the Basic Structure:

  • The dataset consists of various columns containing different data related to vaccinations, testing, hospitalization, cases, deaths, policy responses, and other key variables.
  • Each row represents data for a specific country or region at a certain point in time.

• Selecting Desired Columns:

  • Identify the specific columns that are relevant to your analysis or research needs.
  • Some important columns include population, total cases, total deaths, new cases per million people, and vaccination-related metrics.

• Filtering Data:

  • Use filters based on specific conditions such as date ranges or continents to focus on relevant subsets of data.
  • This can help you analyze trends over time or compare data between different regions.

• Analyzing Vaccination Metrics:

  • Explore variables like total_vaccinations, people_vaccinated, and people_fully_vaccinated to assess vaccination coverage in different countries.
  • Calculate metrics such as people_vaccinated_per_hundred or total_boosters_per_hundred for standardized comparisons across populations.

• Investigating Testing Information:

  • Examine columns such as total_tests, new_tests, and tests_per_case to understand testing efforts in various countries.
  • Calculate rates like tests_per_case to assess testing efficiency or identify changes in testing strategies over time.

• Exploring Hospitalization and ICU Data:

  • Analyze variables like hosp_patients, icu_patients, and hospital_beds_per_thousand to understand healthcare systems' strain.
  • Calculate rates like icu_patients_per_million or hosp_patients_per_million for cross-country comparisons.

• Assessing Covid-19 Cases and Deaths:

  • Analyze variables like total_cases, new_ca...

Effective June 28, 2023, this dataset will no longer be updated. Similar data are accessible from CDC WONDER (https://wonder.cdc.gov/mcd-icd10-provisional.html).

Deaths involving coronavirus disease 2019 (COVID-19) with a focus on ages 0-18 years in the United States.

This dataset is a per-state amalgamation of demographic, public health and other relevant predictors for COVID-19.

Deaths, Infections and Tests by State

The COVID Tracking Project: https://covidtracking.com/data/api

Used positive, death and totalTestResults from the API for, respectively, Infected, Deaths and Tested in this dataset. Please read the documentation of the API for more context on those columns

Predictor Data and Sources

Population (2020)

Density is people per meter squared https://worldpopulationreview.com/states/

ICU Beds and Age 60+

https://khn.org/news/as-coronavirus-spreads-widely-millions-of-older-americans-live-in-counties-with-no-icu-beds/

GDP

https://worldpopulationreview.com/states/gdp-by-state/

Income per capita (2018)

https://worldpopulationreview.com/states/per-capita-income-by-state/

Gini

https://en.wikipedia.org/wiki/List_of_U.S._states_by_Gini_coefficient

Unemployment (2020)

Rates from Feb 2020 and are percentage of labor force
https://www.bls.gov/web/laus/laumstrk.htm

Sex (2017)

Ratio is Male / Female
https://www.kff.org/other/state-indicator/distribution-by-gender/

Smoking Percentage (2020)

https://worldpopulationreview.com/states/smoking-rates-by-state/

Influenza and Pneumonia Death Rate (2018)

Death rate per 100,000 people
https://www.cdc.gov/nchs/pressroom/sosmap/flu_pneumonia_mortality/flu_pneumonia.htm

Chronic Lower Respiratory Disease Death Rate (2018)

Death rate per 100,000 people
https://www.cdc.gov/nchs/pressroom/sosmap/lung_disease_mortality/lung_disease.htm

Active Physicians (2019)

https://www.kff.org/other/state-indicator/total-active-physicians/

Hospitals (2018)

https://www.kff.org/other/state-indicator/total-hospitals

Health spending per capita

Includes spending for all health care services and products by state of residence. Hospital spending is included and reflects the total net revenue. Costs such as insurance, administration, research, and construction expenses are not included.
https://www.kff.org/other/state-indicator/avg-annual-growth-per-capita/

Pollution (2019)

Pollution: Average exposure of the general public to particulate matter of 2.5 microns or less (PM2.5) measured in micrograms per cubic meter (3-year estimate)
https://www.americashealthrankings.org/explore/annual/measure/air/state/ALL

Medium and Large Airports

For each state, number of medium and large airports https://en.wikipedia.org/wiki/List_of_the_busiest_airports_in_the_United_States

Temperature (2019)

Note that FL was incorrect in the table, but is corrected in the Hottest States paragraph
https://worldpopulationreview.com/states/average-temperatures-by-state/
District of Columbia temperature computed as the average of Maryland and Virginia

Urbanization (2010)

Urbanization as a percentage of the population https://www.icip.iastate.edu/tables/population/urban-pct-states

Age Groups (2018)

https://www.kff.org/other/state-indicator/distribution-by-age/

School Closure Dates

Schools that haven't closed are marked NaN https://www.edweek.org/ew/section/multimedia/map-coronavirus-and-school-closures.html

Note that some datasets above did not contain data for District of Columbia, this missing data was found via Google searches manually entered.

Data Repository

Dataset name: covid19_rn-br.csv

Version: 1.0

Data collection period: 04/2020 - 08/2021

Dataset Characteristics: Multivalued

Number of Instances: 12,635

Number of Attributes: 16

Missing Values: Yes

Area(s): Health

Sources:

- Primary:

• RegulaRN (https://regulacao.saude.rn.gov.br/sala-situacao/sala_publica/).

- Secondary:

• RN Mais Vacina (https://rnmaisvacina.lais.ufrn.br/cidadao/).

Description: The covid19_rn-br.csv dataset is composed of data from individuals who were hospitalized due to the Sars-CoV-2 virus. The data comes from the ecosystem of services that includes the regulatory system for clinical and critical beds related to Covid-19 (RegulaRN) and the vaccination system against Covid-19 that records the data of the general population (RN Mais Vacina) from Rio Grande do Norte state, Brazil. This dataset provides elementary data to analyze the impact of vaccination on patients hospitalized in the state. Table 1 presents the dictionary used during the data analysis.

Table 1: Description of Dataset Features.

Attributes	Description	datatype	Value
usp	Unified Score for Prioritization scale, which combines the parameters described in the quick Sequential Organ Failure Assessment (qSOFA), the Charlson Comorbidity Index (CCI), the Clinical Frailty Scale (CFS) and The Karnofsky Performance Status scores	Numerical	2.0. 3.0, 4.0, 5.0, 6.0+
age	Informs the patient's age	Numerical.	integer value for age
outcome	Informs the outcome of the hospitalized patient after leaving the hospital	Categorical	“Discharge” or “Death"
comorbidities	Informs if the patient has comorbidities	Categorical.	“Yes” or “No”
vaccine	Informs which type of vaccine was applied to the patient	Categorical	“Vaccine #1”, “Vaccine #2” or NaN
bed_date_admission	Informs the date the patient was hospitalized	Date	Date
bed_date_outcome	Informs the date that the patient left the hospital bed	Date	Date
length_hospitalization	Informs the number of days that the patient was hospitalized	Numerical	An integer value for days
interval_d1_hospitalization	Informs the interval (in days) that the patient had between the first dose and admission	Numerical	An integer value for days or NaN
interval_d2_hospitalization	Informs the interval (in days) that the patient had between the second dose and admission	Numerical	An integer value for days or NaN
dt_d1	Informs the date of application of the patient's first dose	Date	Date or NaN
dt_d2	Informs the patient's second dose application date	Date	Date or NaN
comorbidities_txt	Informs patients' comorbidities	Categorical	Free text or NaN
immunization	It informs the patient's immunization level according to the number of doses received and the interval (in days) of application of these doses	Categorical	“Partially”, “Fully” or “Not vaccinated”
health_professionals	Informs if the patient is a health professional	Boolean	0 or 1
age_group	Informs the age group of the hospitalized patient according to their age	Categorical	0-19, 20-49, 50-59, 60-69, 70-79, 80-89, 90+

Article: Effectiveness of COVID-19 vaccination on reduction of hospitalizations and deaths in elderly patients in Rio Grande do Norte, Brazil

Authors: Ana Isabela L. Sales-Moioli, Leonardo J. Galvão-Lima, Talita K. B. Pinto, Pablo H. Cardoso, Rodrigo D. Silva, Felipe Fernandes, Ingridy M. P. Barbalho, Fernando L. O. Farias, Nicolas V. R. Veras, Gustavo F. Souza, Agnaldo S. Cruz, Ion G. M. Andrade, Lúcio Gama, Ricardo A. M. Valentim

Final Dataset usted to estimate number of deaths directly avoided because of COVID-19 vaccination among older adults in Colombia.All the original data used to conform the final dataset of this study are of public access and can be downloaded from the official websites. The links to access them are shown below:

The dataset with all the COVID-19 confirmed cases and deaths in Colombia at an individual level is public available at the following link: https://www.datos.gov.co/widgets/gt2j-8ykr?mobile_redirect=true

A dataset with the information on deaths by epidemiological week between vaccinated and unvaccinated by age group is public available at the following link: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/anexos-reportes-tecnicos-cohorte-esperanza.zip

For its part, information on vaccination coverage in Colombia by age group can be consulted at the following link:

https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx

According to Colombian legislation, for more detailed information and to have access to more specific information, researchers must send a formal request to the Ministry of Health and Social Protection.

Inspiration

Which countries have the most social contacts in the world? In particular, do countries with more social contacts among the elderly report more deaths caused by a pandemic caused by a respiratory virus?

Context

With the emergence of the COVID-19 pandemic, reports have shown that the elderly are at a higher risk of dying than any other age groups. 8 out of 10 deaths reported in the U.S. have been in adults 65 years old and older. Countries have also began to enforce 2km social distancing to contain the pandemic.

To this end, I wanted to explore the relationship between social contacts among the elderly and its relationship with the number of COVID-19 deaths across countries.

Content

This dataset includes a subset of the projected social contact matrices in 152 countries from surveys Prem et al. 2020. It was based on the POLYMOD study where information on social contacts was obtained using cross-sectional surveys in Belgium (BE), Germany (DE), Finland (FI), Great Britain (GB), Italy (IT), Luxembourg (LU), The Netherlands (NL), and Poland (PL) between May 2005 and September 2006.

This dataset includes contact rates from study participants ages 65+ for all countries from all sources of contact (work, home, school and others).

I used this R code to extract this data:

load('../input/contacts.Rdata') # https://github.com/kieshaprem/covid19-agestructureSEIR-wuhan-social-distancing/blob/master/data/contacts.Rdata
View(contacts)
contacts[["ALB"]][["home"]]
contacts[["ITA"]][["all"]]
rowSums(contacts[["ALB"]][["all"]])
out1 = data.frame(); for (n in names(contacts)) { x = (contacts[[n]][["all"]])[16,]; out <- rbind(out, data.frame(x)) }
out2 = data.frame(); for (n in names(contacts)) { x = (contacts[[n]][["all"]])[15,]; out <- rbind(out, data.frame(x)) }
out3 = data.frame(); for (n in names(contacts)) { x = (contacts[[n]][["all"]])[14,]; out <- rbind(out, data.frame(x)) }
m1 = data.frame(t(matrix(unlist(out1), nrow=16)))
m2 = data.frame(t(matrix(unlist(out2), nrow=16)))
m3 = data.frame(t(matrix(unlist(out3), nrow=16)))
rownames(m1) = names(contacts)
colnames(m1) = c("00_04", "05_09", "10_14", "15_19", "20_24", "25_29", "30_34", "35_39", "40_44", "45_49", "50_54", "55_59", "60_64", "65_69", "70_74", "75_79")
rownames(m2) = rownames(m1)
rownames(m3) = rownames(m1)
colnames(m2) = colnames(m1)
colnames(m3) = colnames(m1)
write.csv(zapsmall(m1),"contacts_75_79.csv", row.names = TRUE)
write.csv(zapsmall(m2),"contacts_70_74.csv", row.names = TRUE)
write.csv(zapsmall(m3),"contacts_65_69.csv", row.names = TRUE)

Rows names correspond to the 3 letter country ISO code, e.g. ITA represents Italy. Column names are the age groups of the individuals contacted in 5 year intervals from 0 to 80 years old. Cell values are the projected mean social contact rate.

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F1139998%2Ffa3ddc065ea46009e345f24ab0d905d2%2Fcontact_distribution.png?generation=1588258740223812&alt=media" alt="">

Acknowledgements

Thanks goes to Dr. Kiesha Prem for her correspondence and her team for publishing their work on social contact matrices.

References

• The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
• Projecting social contact matrices in 152 countries using contact surveys and demographic data
• Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases (POLYMOD study)

Related resources

• My starter notebook
• http://www.socialcontactdata.org/
• https://www.kaggle.com/tsubasatwi/close-contact-status-of-corona-in-japan
• Facebook Data for Good Mobility Dashboard

A. SUMMARY This archived dataset includes data for population characteristics that are no longer being reported publicly. The date on which each population characteristic type was archived can be found in the field “data_loaded_at”.

B. HOW THE DATASET IS CREATED Data on the population characteristics of COVID-19 cases are from:  * Case interviews  * Laboratories  * Medical providers    These multiple streams of data are merged, deduplicated, and undergo data verification processes.  

Race/ethnicity * We include all race/ethnicity categories that are collected for COVID-19 cases. * The population estimates for the "Other" or “Multi-racial” groups should be considered with caution. The Census definition is likely not exactly aligned with how the City collects this data. For that reason, we do not recommend calculating population rates for these groups.

Gender * The City collects information on gender identity using these guidelines.

Skilled Nursing Facility (SNF) occupancy * A Skilled Nursing Facility (SNF) is a type of long-term care facility that provides care to individuals, generally in their 60s and older, who need functional assistance in their daily lives.  * This dataset includes data for COVID-19 cases reported in Skilled Nursing Facilities (SNFs) through 12/31/2022, archived on 1/5/2023. These data were identified where “Characteristic_Type” = ‘Skilled Nursing Facility Occupancy’.

Sexual orientation * The City began asking adults 18 years old or older for their sexual orientation identification during case interviews as of April 28, 2020. Sexual orientation data prior to this date is unavailable. * The City doesn’t collect or report information about sexual orientation for persons under 12 years of age. * Case investigation interviews transitioned to the California Department of Public Health, Virtual Assistant information gathering beginning December 2021. The Virtual Assistant is only sent to adults who are 18+ years old. https://www.sfdph.org/dph/files/PoliciesProcedures/COM9_SexualOrientationGuidelines.pdf">Learn more about our data collection guidelines pertaining to sexual orientation.

Comorbidities * Underlying conditions are reported when a person has one or more underlying health conditions at the time of diagnosis or death.

Homelessness Persons are identified as homeless based on several data sources: * self-reported living situation * the location at the time of testing * Department of Public Health homelessness and health databases * Residents in Single-Room Occupancy hotels are not included in these figures. These methods serve as an estimate of persons experiencing homelessness. They may not meet other homelessness definitions.

Single Room Occupancy (SRO) tenancy * SRO buildings are defined by the San Francisco Housing Code as having six or more "residential guest rooms" which may be attached to shared bathrooms, kitchens, and living spaces. * The details of a person's living arrangements are verified during case interviews.

Transmission Type * Information on transmission of COVID-19 is based on case interviews with individuals who have a confirmed positive test. Individuals are asked if they have been in close contact with a known COVID-19 case. If they answer yes, transmission category is recorded as contact with a known case. If they report no contact with a known case, transmission category is recorded as community transmission. If the case is not interviewed or was not asked the question, they are counted as unknown.

C. UPDATE PROCESS This dataset has been archived and will no longer update as of 9/11/2023.

D. HOW TO USE THIS DATASET Population estimates are only available for age groups and race/ethnicity categories. San Francisco population estimates for race/ethnicity and age groups can be found in a view based on the San Francisco Population and Demographic Census dataset. These population estimates are from the 2016-2020 5-year American Community Survey (ACS).

This dataset includes many different types of characteristics. Filter the “Characteristic Type” column to explore a topic area. Then, the “Characteristic Group” column shows each group or category within that topic area and the number of cases on each date.

New cases are the count of cases within that characteristic group where the positive tests were collected on that specific specimen collection date. Cumulative cases are the running total of all San Francisco cases in that characteristic group up to the specimen collection date listed.

This data may not be immediately available for recently reported cases. Data updates as more information becomes available.

To explore data on the total number of cases, use the ARCHIVED: COVID-19 Cases Over Time dataset.

E. CHANGE LOG

• 9/11/2023 - data on COVID-19 cases by population characteristics over time are no longer being updated. The date on which each population characteristic type was archived can be found in the field “data_loaded_at”.
• 6/6/2023 - data on cases by transmission type have been removed. See section ARCHIVED DATA for more detail.
• 5/16/2023 - data on cases by sexual orientation, comorbidities, homelessness, and single room occupancy have been removed. See section ARCHIVED DATA for more detail.
• 4/6/2023 - the State implemented system updates to improve the integrity of historical data.
• 2/21/2023 - system updates to improve reliability and accuracy of cases data were implemented.
• 1/31/2023 - updated “population_estimate” column to reflect the 2020 Census Bureau American Community Survey (ACS) San Francisco Population estimates.
• 1/5/2023 - data on SNF cases removed. See section ARCHIVED DATA for more detail.
• 3/23/2022 - ‘Native American’ changed to ‘American Indian or Alaska Native’ to align with the census.
• 1/22/2022 - system updates to improve timeliness and accuracy of cases and deaths data were implemented.
• 7/15/2022 - reinfections added to cases dataset. See section SUMMARY for more information on how reinfections are identified.

Taiwan recorded 7917 Coronavirus Deaths since the epidemic began, according to the World Health Organization (WHO). In addition, Taiwan reported 4189929 Coronavirus Cases. This dataset includes a chart with historical data for Taiwan Coronavirus Deaths.

Provisional counts of deaths in care homes caused by coronavirus (COVID-19) by local authority. Published by the Office for National Statistics and Care Quality Commission.

Introduction: Older adults are more susceptible to severe COVID-19, with increased all-cause mortality. This has been attributed to their multimorbidity and disability. However, it remains to be established which clinical features of older adults are associated with severe COVID-19 and mortality. This information would aid in an accurate prognosis and appropriate care planning. Here, we aimed to identify the chronic clinical conditions and the comorbidity clusters associated with in-hospital mortality in a cohort of older COVID-19 patients who were admitted to the IRCCS Policlinico San Martino Hospital, Genoa, Italy, between January and April 2020.Methods: This was a retrospective cohort study including 219 consecutive patients aged 70 years or older and is part of the GECOVID-19 study group. During the study period, upon hospital admission, demographic information (age, sex) and underlying chronic medical conditions (multimorbidity) were recorded from the medical records at the time of COVID-19 diagnosis before any antiviral or antibiotic treatment was administered. The primary outcome measure was in-hospital mortality.Results: The vast majority of the patients (90%) were >80 years; the mean patient age was 83 ± 6.2 years, and 57.5% were men. Hypertension and cardiovascular disease, along with dementia, cerebrovascular diseases, and vascular diseases were the most prevalent clinical conditions. Multimorbidity was assessed with the Cumulative Illness Rating Scale. The risk of in-hospital mortality due to COVID-19 was higher for males, for older patients, and for patients with dementia or cerebral-vascular disease. We clustered patients into three groups based on their comorbidity pattern: the Metabolic-renal-cancer cluster, the Neurocognitive cluster and the Unspecified cluster. The Neurocognitive and Metabolic-renal-cancer clusters had a higher mortality compared with the Unspecified cluster, independent of age and sex.Conclusion: We defined patterns of comorbidity that accurately identified older adults who are at higher risk of death from COVID-19. These associations were independent of chronological age, and we suggest that the identification of comorbidity clusters that have a common pathophysiology may aid in the early assessment of COVID-19 patients with frailty to promote timely interventions that, in turn, may result in a significantly improved prognosis.

Deaths were determined to be COVID-associated if they met the Department of Public Health's surveillance definition at the time of death.The cumulative COVID-19 mortality rate can be used to measure the most severe impacts of COVID-19 in a community. There have been documented inequities in COVID-19 mortality rates by demographic and geographic factors. Black and Brown residents, seniors, and those living in areas with higher rates of poverty have all been disproportionally impacted.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

Provisional counts of the number of deaths registered in England and Wales, by age, sex, region and Index of Multiple Deprivation (IMD), in the latest weeks for which data are available.